These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29077803)

  • 1. Cognitive and Neuropsychiatric Features of Early Parkinson's Disease.
    Getz SJ; Levin B
    Arch Clin Neuropsychol; 2017 Nov; 32(7):769-785. PubMed ID: 29077803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Concept of Prodromal Parkinson's Disease.
    Mahlknecht P; Seppi K; Poewe W
    J Parkinsons Dis; 2015; 5(4):681-97. PubMed ID: 26485429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease.
    Poletti M; Frosini D; Pagni C; Baldacci F; Nicoletti V; Tognoni G; Lucetti C; Del Dotto P; Ceravolo R; Bonuccelli U
    J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):601-6. PubMed ID: 22492216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mild cognitive impairment in Parkinson's disease].
    Wada K; Nakashima K
    Brain Nerve; 2012 Dec; 64(12):1365-75. PubMed ID: 23209063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive changes in prodromal Parkinson's disease: A review.
    Fengler S; Liepelt-Scarfone I; Brockmann K; Schäffer E; Berg D; Kalbe E
    Mov Disord; 2017 Dec; 32(12):1655-1666. PubMed ID: 28980730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and behavioral assessment in Parkinson's disease.
    Martinez-Horta S; Horta-Barba A; Kulisevsky J
    Expert Rev Neurother; 2019 Jul; 19(7):613-622. PubMed ID: 31180250
    [No Abstract]   [Full Text] [Related]  

  • 8. Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment.
    Goldman JG; Holden SK; Litvan I; McKeith I; Stebbins GT; Taylor JP
    Mov Disord; 2018 Apr; 33(4):503-510. PubMed ID: 29488270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging correlates of cognitive impairment and dementia in Parkinson's disease.
    Mak E; Su L; Williams GB; O'Brien JT
    Parkinsonism Relat Disord; 2015 Aug; 21(8):862-70. PubMed ID: 26004683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of Nonmotor Symptoms in Parkinson's Disease.
    Konno T; Al-Shaikh RH; Deutschländer AB; Uitti RJ
    Int Rev Neurobiol; 2017; 133():259-289. PubMed ID: 28802922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a need to redefine Parkinson's disease?
    Mahlknecht P; Poewe W
    J Neural Transm (Vienna); 2013 Sep; 120 Suppl 1():S9-17. PubMed ID: 23715973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological correlates of prospective memory: A comparison between tremor-dominant Parkinson's disease and cervical dystonia.
    D'Iorio A; Esposito M; Maggi G; Amboni M; Vitale C; Santangelo G
    J Clin Neurosci; 2021 May; 87():156-161. PubMed ID: 33863525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild cognitive impairment and cognitive reserve in Parkinson's disease.
    Poletti M; Emre M; Bonuccelli U
    Parkinsonism Relat Disord; 2011 Sep; 17(8):579-86. PubMed ID: 21489852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropsychiatric manifestations in Parkinson's disease].
    Oikonomou E; Paparrigopoulos T
    Psychiatriki; 2015; 26(2):116-30. PubMed ID: 26197101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.
    Gasser AI; Calabrese P; Kalbe E; Kessler J; Rossier P
    Rev Neurol (Paris); 2016 Feb; 172(2):138-45. PubMed ID: 26494570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial cognitive changes in Parkinson's disease.
    Weintraub D; Tröster AI; Marras C; Stebbins G
    Mov Disord; 2018 Apr; 33(4):511-519. PubMed ID: 29543342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease.
    Stav AL; Aarsland D; Johansen KK; Hessen E; Auning E; Fladby T
    Parkinsonism Relat Disord; 2015 Jul; 21(7):758-64. PubMed ID: 25971633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's and Alzheimer's diseases: Focus on mild cognitive impairment.
    Korczyn AD
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S159-61. PubMed ID: 26516060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's at risk syndrome: can Parkinson's disease be predicted?
    Stern MB; Siderowf A
    Mov Disord; 2010; 25 Suppl 1():S89-93. PubMed ID: 20187248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive and Neuropsychiatric Features in Parkinson's and Lewy Body Dementias.
    Fields JA
    Arch Clin Neuropsychol; 2017 Nov; 32(7):786-801. PubMed ID: 28961866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.